MEK is downstream of the RAS-RAF-MEK-ERK pathway (ERK signaling), which had been recognized as the most frequently hyperactivated pathway in human cancers, including NSCLC [35,36]. The gene discussed is MAPK1; the disease is non-small cell lung carcinoma.